Provide the full range of services required to support DCR in its provision of support services, oversight, and management of intramural clinical research, program planning and management,…
Ended Awarded Last action
- Contract number
- 75N91019F00130
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $63,059,337
Award facts
- Opportunity
-
- N02CO7240681 Solicitation number
- Contract value 94% obligated
- $67,071,640.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,690,270 | |
| Funding Only Action | $5,070,370 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $60,679,237 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Leidos Biomedical Research Inc. on August 31, 2019, with a ceiling value of $67.1 million under a cost-plus-fixed-fee structure.
This delivery order supports the full range of services required by the NIAID Division of Clinical Research in provision of support services, oversight, and management of intramural clinical research, program planning and management, regulatory monitoring and compliance, and statistical consultation. Place of performance is Frederick, MD. The ultimate completion date is August 30, 2020.
In fiscal year 2020, the order generated $51 million in government-invoiced labor with 17 subcontractors engaged in support of performance.
Description
Provide the full range of services required to support DCR in its provision of support services, oversight, and management of intramural clinical research, program planning and management, regulatory monitoring and compliance, statistical consultatio
Quick answers
Who was awarded contract 75N91019F00130?
75N91019F00130 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2019.
How much is contract 75N91019F00130 worth?
The government has obligated $63,059,337 on 75N91019F00130. Its current value, with exercised options, is $67,071,640.
Which agency awarded contract 75N91019F00130?
National Cancer Institute (National Institutes of Health) awarded 75N91019F00130, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91019F00130 an order under another contract?
Yes. 75N91019F00130 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91019F00130 competed?
The extent of competition for 75N91019F00130 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award